Loading…
Based on limited metadata without access to the full warning letter text, this FDA Warning Letter issued to Eosera, Inc. on July 13, 2020, concerns a product classified as "Other" — suggesting it does not fit standard device, drug, or biological categories. Without a detailed subject line, the specific nature of the regulatory violations cannot be determined from the available information. The issuing office is not identified in the metadata provided, limiting clarity on the specific FDA division overseeing this enforcement action.